Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22,143 | 11 | 58.3% |
| Travel and Lodging | $6,203 | 12 | 16.3% |
| Food and Beverage | $3,827 | 68 | 10.1% |
| Consulting Fee | $3,600 | 1 | 9.5% |
| Honoraria | $2,000 | 1 | 5.3% |
| Education | $215.49 | 8 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Vifor Pharma, Inc. | $18,128 | 20 | $0 (2023) |
| Relypsa, Inc. | $16,048 | 31 | $0 (2020) |
| Fresenius USA Marketing, Inc. | $2,132 | 3 | $0 (2023) |
| Amgen Inc. | $305.43 | 6 | $0 (2024) |
| Mallinckrodt LLC | $243.09 | 2 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $239.59 | 6 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $238.29 | 2 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $195.90 | 6 | $0 (2022) |
| Travere Therapeutics, Inc. | $188.83 | 6 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $181.85 | 13 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $571.02 | 14 | Novartis Pharmaceuticals Corporation ($239.59) |
| 2023 | $2,467 | 10 | Fresenius USA Marketing, Inc. ($2,132) |
| 2022 | $18,346 | 27 | Vifor Pharma, Inc. ($18,099) |
| 2021 | $187.05 | 14 | Mallinckrodt Hospital Products Inc. ($146.96) |
| 2020 | $22.35 | 1 | Relypsa, Inc. ($22.35) |
| 2019 | $209.88 | 2 | Relypsa, Inc. ($209.88) |
| 2018 | $9,573 | 17 | Relypsa, Inc. ($9,214) |
| 2017 | $6,612 | 16 | Relypsa, Inc. ($6,602) |
All Payment Transactions
101 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $100.97 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $31.43 | General |
| Category: Immunology | ||||||
| 09/13/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/08/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $33.64 | General |
| 08/06/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/25/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $25.77 | General |
| 07/23/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $13.75 | General |
| 05/28/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $28.15 | General |
| 05/09/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $113.30 | General |
| 05/03/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $15.98 | General |
| 03/09/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $112.59 | General |
| Category: Inflammation | ||||||
| 03/01/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/05/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $29.86 | General |
| Category: Inflammation | ||||||
| 12/14/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $149.86 | General |
| 10/24/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 10/24/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 10/24/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 07/17/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Phosphate binder for ESRD | ||||||
| 07/05/2023 | Fresenius USA Marketing, Inc. | KORSUVA (Drug) | Honoraria | Cash or cash equivalent | $2,000.00 | General |
| Category: KORSUVA a Kappa opioid receptor agonist for pruritus companied with chronic kidney disease CKD-aP | ||||||
| 06/22/2023 | Fresenius USA Marketing, Inc. | KORSUVA (Drug) | Food and Beverage | Cash or cash equivalent | $111.12 | General |
| Category: KORSUVA a Kappa opioid receptor agonist for pruritus companied with chronic kidney disease CKD-aP | ||||||
| 06/14/2023 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 03/04/2023 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $28.78 | General |
| Category: Hyperkalemia | ||||||
| 02/10/2023 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Inflammation | ||||||
| 11/28/2022 | Vifor Pharma, Inc. | Korsuva (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,090.00 | General |
| Category: CKD-aP | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 464 | 1,217 | $410,635 | $183,814 |
| 2022 | 8 | 541 | 1,455 | $532,348 | $237,004 |
| 2021 | 8 | 589 | 1,638 | $603,695 | $283,801 |
| 2020 | 10 | 704 | 1,865 | $686,695 | $266,688 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 74 | 536 | $268,000 | $129,321 | 48.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 105 | 280 | $42,280 | $18,233 | 43.1% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 45 | 99 | $38,412 | $16,664 | 43.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 129 | 170 | $26,690 | $8,073 | 30.2% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 14 | 19 | $11,286 | $5,616 | 49.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 73 | $16,790 | $3,448 | 20.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $3,113 | $1,188 | 38.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $3,648 | $1,172 | 32.1% |
| 99421 | Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | Office | 2023 | 13 | 13 | $416.00 | $100.24 | 24.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 108 | 762 | $381,000 | $185,236 | 48.6% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 71 | 144 | $55,984 | $23,633 | 42.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 165 | 247 | $38,779 | $10,599 | 27.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 70 | 152 | $22,952 | $8,438 | 36.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 63 | 82 | $18,860 | $4,002 | 21.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 18 | 19 | $5,377 | $2,036 | 37.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 25 | 25 | $5,700 | $1,730 | 30.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 21 | 24 | $3,696 | $1,331 | 36.0% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 117 | 845 | $422,500 | $207,630 | 49.1% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2021 | 82 | 196 | $76,048 | $33,516 | 44.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 170 | 267 | $41,919 | $16,972 | 40.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 86 | 122 | $28,060 | $12,600 | 44.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 79 | 148 | $22,348 | $8,740 | 39.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 18 | 18 | $5,094 | $1,816 | 35.7% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 20 | 25 | $3,850 | $1,466 | 38.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 17 | 17 | $3,876 | $1,060 | 27.4% |
About Dr. David Pai, MD
Dr. David Pai, MD is a Specialist healthcare provider based in Sacramento, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023190808.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Pai, MD has received a total of $37,989 in payments from pharmaceutical and medical device companies, with $571.02 received in 2024. These payments were reported across 101 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($22,143).
As a Medicare-enrolled provider, Pai has provided services to 2,298 Medicare beneficiaries, totaling 6,175 services with total Medicare billing of $971,307. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Sacramento, CA
- Active Since 10/20/2006
- Last Updated 03/07/2012
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1023190808
Products in Payments
- Veltassa (Drug) $16,178
- Korsuva (Drug) $2,791
- KORSUVA (Drug) $2,111
- ACTHAR (Biological) $424.94
- LUPKYNIS (Drug) $195.90
- TAVNEOS (Drug) $164.08
- Fabhalta (Drug) $152.03
- Parsabiv (Biological) $103.50
- IBSRELA (Drug) $31.10
- Tavneos (Drug) $23.00
- Velphoro (Drug) $21.29
- LOKELMA (Drug) $20.35
- KRYSTEXXA (Biological) $14.85
- BENLYSTA (Biological) $12.88
- JYNARQUE (Drug) $12.51
- Uloric (Drug) $10.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Sacramento
Dr. Jeffrey Gregg, M.d, M.D
Specialist — Payments: $1.2M
Mehrad Abedi, M.d, M.D
Specialist — Payments: $809,018
Dr. Nancy Lane, M.d, M.D
Specialist — Payments: $434,011
Dr. Naveen Atray, M.d, M.D
Specialist — Payments: $99,483
William Cushard, M.d, M.D
Specialist — Payments: $31,555
Dr. Christopher Polage, M.d, M.D
Specialist — Payments: $18,465